ABL Bio Inc (298380)

Currency in KRW
75,200
-7,300(-8.85%)
Closed·
298380 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
74,60080,000
52 wk Range
59,800257,500
Key Statistics
Bid/Ask
75,200.00 / 75,300.00
Prev. Close
82,500
Open
79,800
Day's Range
74,600-80,000
52 wk Range
59,800-257,500
Volume
286.38K
Average Volume (3m)
403.74K
1-Year Change
-8.0685%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
298380 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
257,500
Upside
+242.42%
Members' Sentiments
Bearish
Bullish
ProTips
Stock generally trades with high price volatility

ABL Bio Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Analyst Ratings

4 Buy
0 Hold
0 Sell
Ratings:
4 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 257,500
(+242.42% Upside)

Earnings

Latest Release
08-05-2026
EPS / Forecast
-260.86 / -150.21
Revenue / Forecast
13.14B / --
EPS Revisions
Last 90 days

298380 Income Statement

Compare 298380 to Peers and Sector

Metrics to compare
298380
Peers
Sector
Relationship
P/E Ratio
−174.4x−14.6x−0.4x
PEG Ratio
−2.51−0.070.00
Price/Book
23.3x2.4x2.6x
Price / LTM Sales
46.6x9.2x3.1x
Upside (Analyst Target)
245.7%33.5%48.9%
Fair Value Upside
Unlock9.5%6.2%Unlock

ABL Bio Inc., a biotech research company, focuses on the development of therapeutic drugs for immuno-oncology and neurodegenerative diseases. The company offers ABL301, which is in the phase 1 clinical stage for the treatment of parkinson’s disease; ABL503 and ABL111 that is in phase 1 clinical stage for the treatment of solid tumor; and ABL102 for the treatment of solid and blood tumor. It also provides ABL103 for the treatment solid cancers; ABL104 for the treatment of solid tumor; and ABL105, which is in phase 1 clinical stage for the treatment of solid tumor. ABL Bio Inc. was incorporated in 2016 and is based in Seoul, South Korea.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
3.97M7.10%298.72B
Other Institutional Investors
4.45M7.95%334.53B
Public Companies & Retail Investors
47.57M84.96%3.58T
Total
55.99M100.00%4.21T

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
National Pension Service3.97%22,24,08716,72,51,342
The National Pension Fund3.97%22,24,08716,72,51,342

FAQ

What Is the ABL Bio (298380) Share Price Today?

The ABL Bio share price today is 75,200.

What is the current ABL Bio (298380) share price and day range?

As of 23-08-2026, the ABL Bio share price is 75,200, with a previous close of 82,500. The share price has ranged from 74,600 to 80,000 today, while the 52-week range spans from 59,800 to 2,57,500.

What Is the ABL Bio Market Cap?

As of today, ABL Bio market cap is 4.21T.

What Is the ABL Bio (298380) Share Price Target?

The average 12-month share price target for ABL Bio is 2,57,500, with a high estimate of 280000 and a low estimate of 230000. 4 analysts recommend buying, while 0 suggest selling, with an overall rating of Buy and +242.42% Upside potential.

What Is ABL Bio's Earnings Per Share (TTM)?

The ABL Bio EPS (TTM) is -453.

From a Technical Analysis Perspective, Is 298380 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

What Stock Exchange Does ABL Bio Trade On?

ABL Bio is listed and trades on the KOSDAQ.

What Is the Stock Symbol for ABL Bio?

The stock symbol for ABL Bio is "298380."

How Many Times Has ABL Bio Stock Split?

ABL Bio has split 0 times.

How Many Employees Does ABL Bio Have?

ABL Bio has 102 employees.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.